Natixis Takes Position in Schrödinger, Inc. (NASDAQ:SDGR)

Natixis bought a new position in shares of Schrödinger, Inc. (NASDAQ:SDGR - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 90,700 shares of the company's stock, valued at approximately $1,750,000. Natixis owned about 0.12% of Schrödinger at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in the business. Paradigm Asset Management Co. LLC purchased a new position in shares of Schrödinger during the 4th quarter valued at about $50,000. GAMMA Investing LLC lifted its holdings in Schrödinger by 87.5% in the fourth quarter. GAMMA Investing LLC now owns 2,796 shares of the company's stock valued at $54,000 after acquiring an additional 1,305 shares during the period. KBC Group NV boosted its position in Schrödinger by 73.9% in the 4th quarter. KBC Group NV now owns 4,361 shares of the company's stock worth $84,000 after purchasing an additional 1,853 shares in the last quarter. XTX Topco Ltd acquired a new stake in shares of Schrödinger during the 4th quarter worth approximately $199,000. Finally, Proficio Capital Partners LLC purchased a new position in shares of Schrödinger during the 4th quarter valued at approximately $218,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Schrödinger Trading Down 0.8 %

Shares of Schrödinger stock opened at $25.99 on Wednesday. Schrödinger, Inc. has a twelve month low of $16.60 and a twelve month high of $28.47. The firm's 50-day moving average price is $22.09 and its 200 day moving average price is $21.12. The firm has a market capitalization of $1.90 billion, a PE ratio of -11.11 and a beta of 1.77.

Schrödinger (NASDAQ:SDGR - Get Free Report) last issued its quarterly earnings results on Wednesday, February 26th. The company reported ($0.55) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.35) by ($0.20). The firm had revenue of $88.32 million during the quarter, compared to analyst estimates of $83.20 million. Schrödinger had a negative return on equity of 35.77% and a negative net margin of 91.84%. On average, sell-side analysts predict that Schrödinger, Inc. will post -2.37 EPS for the current fiscal year.

Analysts Set New Price Targets

SDGR has been the topic of a number of recent analyst reports. KeyCorp raised their price target on shares of Schrödinger from $30.00 to $32.00 and gave the company an "overweight" rating in a research report on Wednesday, April 16th. Piper Sandler dropped their target price on Schrödinger from $50.00 to $45.00 and set an "overweight" rating on the stock in a research report on Thursday, February 27th. One research analyst has rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Buy" and a consensus price target of $33.00.

Insider Activity

In related news, CFO Geoffrey Craig Porges sold 5,491 shares of the stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $21.76, for a total value of $119,484.16. Following the completion of the sale, the chief financial officer now owns 27,544 shares of the company's stock, valued at approximately $599,357.44. This trade represents a 16.62 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Karen Akinsanya sold 16,723 shares of the business's stock in a transaction on Monday, April 14th. The stock was sold at an average price of $25.09, for a total value of $419,580.07. Following the transaction, the insider now directly owns 15,625 shares in the company, valued at $392,031.25. This trade represents a 51.70 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 8.60% of the company's stock.

Schrödinger Company Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.